Cannara Biotech (OTC:LOVFF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cannara Biotech (LOVFF) operate in?

Cannara Biotech is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Cannara Biotech Stock (OTC: LOVFF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 3.34K
Day Range	- - -
52 Wk Range	0.39 - 0.84
Market Cap	$36.10M
P/E Ratio	7.82
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going

In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable shifts in sales dynamics among leading licensed producers (LPs).

Nicolás Jose Rodriguez

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68% year-over-year increase in revenues for the first half of fiscal 2024, a metrics CFO Nicholas Sosiak called "a testament to our growing influence in the Quebec, Ontario, Alberta, and BC markets." "Our proactive steps towards streamlining assets align with our ambition to fortify our financial foundation as we relentlessly stay focused on gaining market share and becoming the leader in Canada, the second-largest cannabis market in the world," Sosiak said. "As for our long-term vision, we do see our future extend beyond our borders where Cannara is a globally recognized brand synonymous with excellence and value in cannabis."

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About

Sector

Healthcare

Industry

N/A

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-deriv...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cannara Biotech (LOVFF) stock?

You can purchase shares of Cannara Biotech (OTCQB:LOVFF) through any online brokerage.

View our list of the best stock brokerages

Who are Cannara Biotech (LOVFF) competitors?

There are no as such competitors for Cannara Biotech.

What is the target price for Cannara Biotech (LOVFF) stock?

There is no analysis for Cannara Biotech.

What is the forecast for Cannara Biotech (LOVFF) stock?

There is no analysis for Cannara Biotech to provide a consensus price target.

Current stock price for Cannara Biotech (LOVFF)?

The stock price for Cannara Biotech (OTCQB: LOVFF) is $0.401 last updated July 12, 2024 at 1:58 PM EDT.

Does Cannara Biotech (LOVFF) pay a dividend?

There are no upcoming dividends for Cannara Biotech.

When is Cannara Biotech (OTCQB:LOVFF) reporting earnings?

Cannara Biotech does not have any upcoming earnings scheduled.

Is Cannara Biotech (LOVFF) going to split?

There is no upcoming split for Cannara Biotech.

What sector and industry does Cannara Biotech (LOVFF) operate in?

Cannara Biotech is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Cannara Biotech

Cannara Biotech (LOVFF) Forecast